Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of u...
Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of uveitis
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Immune checkpoint inhibitors (ICI) such as Programmed cell Death 1 (PD-1) inhibitors have improved cancer treatment by enhancing the immune system's ability to target malignant cells. Their use is associated with immune-related adverse events (irAEs), including uveitis. The profile of pro-inflammatory cytokines underlying Anti-PD-1-induced uveitis...
Alternative Titles
Full title
Cytokines in PD-1 immune checkpoint inhibitor adverse events and implications for the treatment of uveitis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c8d27c81f12444af948e2936232ef0e4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c8d27c81f12444af948e2936232ef0e4
Other Identifiers
ISSN
1471-2415
E-ISSN
1471-2415
DOI
10.1186/s12886-024-03575-7
